The Beijing Centers for Disease Control and Prevention selects Sinovac Biotech Ltd. (SVA +1%) as one of four suppliers of influenza vaccines to the citizens of Beijing for 2014. Each manufacturer will supply a minimum of 300,000 doses, but could be greater depending on demand. Last year, the company supplied ~400K doses of its Anflu vaccine.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs